2015 - Distinguished Scientist Award, American Heart Association
Member of the Association of American Physicians
Samuel Z. Goldhaber mostly deals with Pulmonary embolism, Surgery, Internal medicine, Thrombosis and Cardiology. His Pulmonary embolism research is multidisciplinary, incorporating perspectives in Respiratory disease, Embolism, Thrombolysis, Radiology and Vascular disease. Samuel Z. Goldhaber has included themes like Plasminogen activator, Anesthesia and Tissue plasminogen activator in his Surgery study.
Within one scientific family, he focuses on topics pertaining to Mortality rate under Thrombosis, and may sometimes address concerns connected to Hazard ratio. His research investigates the connection between Cardiology and topics such as Blood pressure that intersect with problems in Autopsy. His research in Venous thrombosis tackles topics such as Intensive care medicine which are related to areas like Anticoagulant, Venous thromboembolic disease and Evidence-based medicine.
Samuel Z. Goldhaber mainly investigates Pulmonary embolism, Internal medicine, Surgery, Cardiology and Thrombosis. His Pulmonary embolism study combines topics from a wide range of disciplines, such as Respiratory disease, Thrombolysis, Intensive care medicine, Radiology and Venous thrombosis. His studies deal with areas such as Venous thromboembolism and Disease as well as Intensive care medicine.
In his research on the topic of Surgery, Anesthesia is strongly related with Warfarin. When carried out as part of a general Cardiology research project, his work on Heart failure and Coronary artery disease is frequently linked to work in In patient, therefore connecting diverse disciplines of study. His work carried out in the field of Thrombosis brings together such families of science as Anticoagulant, Thrombus, Vascular disease and Heparin.
His scientific interests lie mostly in Internal medicine, Pulmonary embolism, Thrombosis, Venous thromboembolism and Cardiology. His Atrial fibrillation, Stroke, Randomized controlled trial and Anticoagulant study, which is part of a larger body of work in Internal medicine, is frequently linked to In patient, bridging the gap between disciplines. His Pulmonary embolism research focuses on Ultrasound and how it connects with Catheter.
His Thrombosis study combines topics in areas such as Thrombolysis, Confidence interval and Intensive care medicine. While the research belongs to areas of Intensive care medicine, Samuel Z. Goldhaber spends his time largely on the problem of Rivaroxaban, intersecting his research to questions surrounding Placebo. His Deep vein research entails a greater understanding of Surgery.
Samuel Z. Goldhaber spends much of his time researching Internal medicine, Stroke, Thrombosis, Pulmonary embolism and Atrial fibrillation. His studies link Cardiology with Internal medicine. His Stroke research includes themes of Prospective cohort study, Cohort study, Bleed and Comorbidity.
His Thrombosis study incorporates themes from Randomized controlled trial, Intensive care medicine, Heparin and Antithrombotic. Samuel Z. Goldhaber brings together Pulmonary embolism and Vital registration to produce work in his papers. His Deep vein study introduces a deeper knowledge of Surgery.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Antithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.
Clive Kearon;Elie A. Akl;Anthony J. Comerota;Paolo Prandoni.
Acute pulmonary embolism: clinical outcomes in the international cooperative pulmonary embolism registry (ICOPER)
Samuel Z Goldhaber;Luigi Visani;Marisa De Rosa.
The Lancet (1999)
Dabigatran versus warfarin in the treatment of acute venous thromboembolism
Sam Schulman;Clive Kearon;Ajay K. Kakkar;Patrick Mismetti.
The New England Journal of Medicine (2009)
Antithrombotic therapy for venous thromboembolic disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).
Clive Kearon;Susan R. Kahn;Giancarlo Agnelli;Samuel Goldhaber.
Management of Massive and Submassive Pulmonary Embolism, Iliofemoral Deep Vein Thrombosis, and Chronic Thromboembolic Pulmonary Hypertension A Scientific Statement From the American Heart Association
Michael R. Jaff;M. Sean McMurtry;Stephen L. Archer;Mary Cushman.
An overview of randomized trials of rehabilitation with exercise after myocardial infarction.
Gerald T. O'connor;Julie E. Buring;Salim Yusuf;Samuel Z. Goldhaber.
COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-up
Behnood Bikdeli;Mahesh V. Madhavan;David Jimenez;Taylor Chuich.
Journal of the American College of Cardiology (2020)
Venous thromboembolism risk and prophylaxis in the acute hospital care setting (ENDORSE study): a multinational cross-sectional study.
Alexander T Cohen;Victor F Tapson;Jean-Francois Bergmann;Samuel Z Goldhaber.
The Lancet (2008)
Moderate Alcohol Intake, Increased Levels of High-Density Lipoprotein and Its Subfractions, and Decreased Risk of Myocardial Infarction
Gaziano Jm;Buring Je;Breslow Jl;Goldhaber Sz.
The New England Journal of Medicine (1993)
Electronic alerts to prevent venous thromboembolism among hospitalized patients
Nils Kucher;Sophia Koo;Rene Quiroz;Joshua M. Cooper.
The New England Journal of Medicine (2005)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: